{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T07:09:17Z","timestamp":1790838557464,"version":"4.1.0"},"reference-count":55,"publisher":"Siapec Servizi Srl","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologica"],"DOI":"10.32074\/1591-951x-241","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T11:10:37Z","timestamp":1625829037000},"page":"185-193","source":"Crossref","is-referenced-by-count":76,"title":["Pathology of autoimmune hepatitis"],"prefix":"10.32074","volume":"113","author":[{"given":"Claudia","family":"Covelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Sacchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Sarcognato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Cazzagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Grillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Baciorri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Fanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Cacciatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Maffeis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Guido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"21774","published-online":{"date-parts":[[2021,6]]},"reference":[{"key":"10.32074\/1591-951X-241_ref1","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: autoimmune hepatitis. J Hepatol 2015;63:971-1004. https:\/\/doi.org\/10.1016\/j.jhep.2015.06.030. Erratum in J Hepatol 2015;63:1543-1544.","DOI":"10.1016\/j.jhep.2015.09.016"},{"key":"10.32074\/1591-951X-241_ref2","doi-asserted-by":"crossref","unstructured":"Assis DN. Immunopathogenesis of autoimmune hepatitis. Clin Liver Dis (Hoboken) 2020;15:129-132. https:\/\/doi.org\/10.1002\/cld.873","DOI":"10.1002\/cld.873"},{"key":"10.32074\/1591-951X-241_ref3","doi-asserted-by":"crossref","unstructured":"Tanaka A. Autoimmune hepatitis: 2019 update. Gut Liver 2020;14:430-438. https:\/\/doi.org\/10.5009\/gnl19261","DOI":"10.5009\/gnl19261"},{"key":"10.32074\/1591-951X-241_ref4","doi-asserted-by":"crossref","unstructured":"Yeoman AD, Al-Chalabi T, Karani JB, et al. Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: implications for follow-up and screening. Hepatology 2008;48:863-870. https:\/\/doi.org\/10.1002\/hep.22432","DOI":"10.1002\/hep.22432"},{"key":"10.32074\/1591-951X-241_ref5","doi-asserted-by":"crossref","unstructured":"Wong RJ, Gish R, Frederick T, et al. Development of hepatocellular carcinoma in autoimmune hepatitis patients: a case series. Dig Dis Sci 2011;56:578-585. https:\/\/doi.org\/10.1007\/s10620-010-1444-6","DOI":"10.1007\/s10620-010-1444-6"},{"key":"10.32074\/1591-951X-241_ref6","doi-asserted-by":"crossref","unstructured":"Czaja AJ. Diagnosis and management of autoimmune hepatitis. Clin Liver Dis 2015;19:57-79. https:\/\/doi.org\/10.1016\/j.cld.2014.09.004","DOI":"10.1016\/j.cld.2014.09.004"},{"key":"10.32074\/1591-951X-241_ref7","doi-asserted-by":"crossref","unstructured":"Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993;18:998-1005. https:\/\/doi.org\/10.1002\/hep.1840180435","DOI":"10.1002\/hep.1840180435"},{"key":"10.32074\/1591-951X-241_ref8","doi-asserted-by":"crossref","unstructured":"Alvarez F, Berg PA, Bianchi FB, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-938. https:\/\/doi.org\/10.1016\/s0168-8278(99)80297-9","DOI":"10.1016\/S0168-8278(99)80297-9"},{"key":"10.32074\/1591-951X-241_ref9","doi-asserted-by":"crossref","unstructured":"Hennes EM, Zeniya M, Czaja AJ, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008;48:169-176. https:\/\/doi.org\/10.1002\/hep.22322","DOI":"10.1002\/hep.22322"},{"key":"10.32074\/1591-951X-241_ref10","doi-asserted-by":"crossref","unstructured":"Zachou K, Muratori P, Koukoulis GK, et al. Review article: autoimmune hepatitis - Current management and challenges. Aliment Pharmacol Ther 2013;38:887-913. https:\/\/doi.org\/10.1111\/apt.12470","DOI":"10.1111\/apt.12470"},{"key":"10.32074\/1591-951X-241_ref11","doi-asserted-by":"crossref","unstructured":"Muratori P, Granito A, Quarneti C, et al. Autoimmune hepatitis in Italy: the Bologna experience. J Hepatol 2009;50:1210-1218. https:\/\/doi.org\/10.1016\/j.jhep.2009.01.020","DOI":"10.1016\/j.jhep.2009.01.020"},{"key":"10.32074\/1591-951X-241_ref12","doi-asserted-by":"crossref","unstructured":"Al-Chalabi T, Underhill JA, Portmann BC, et al. Impact of gender on the long-term outcome and survival of patients with autoimmune hepatitis. J Hepatol 2008;48:140-147. https:\/\/doi.org\/10.1016\/j.jhep.2007.08.013","DOI":"10.1016\/j.jhep.2007.08.013"},{"key":"10.32074\/1591-951X-241_ref13","doi-asserted-by":"crossref","unstructured":"Floreani A, Niro G, Rosa Rizzotto E, et al. Type I autoimmune hepatitis: clinical course and outcome in an Italian multicenter study. Aliment Pharmacol Ther 2006;24:1051-1057. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.03104.x","DOI":"10.1111\/j.1365-2036.2006.03104.x"},{"key":"10.32074\/1591-951X-241_ref14","doi-asserted-by":"crossref","unstructured":"Fujiwara K, Fukuda Y, Yokosuka O. Precise histological evaluation of liver biopsy specimen is indispensable for diagnosis and treatment of acute onset autoimmune hepatitis. J Gastroenterol 2008;43:951-958. https:\/\/doi.org\/10.1007\/s00535-008-2254-x","DOI":"10.1007\/s00535-008-2254-x"},{"key":"10.32074\/1591-951X-241_ref15","doi-asserted-by":"crossref","unstructured":"Yasui S, Fujiwara K, Yonemitsu Y, et al. Clinicopathological features of severe and fulminant forms of autoimmune hepatitis. J Gastroenterol 2011;46:378-390. https:\/\/doi.org\/10.1007\/s00535-010-0316-3","DOI":"10.1007\/s00535-010-0316-3"},{"key":"10.32074\/1591-951X-241_ref16","doi-asserted-by":"crossref","unstructured":"Czaja AJ. Autoantibody-negative autoimmune hepatitis. Dig Dis Sci 2012;57:610-624. https:\/\/doi.org\/10.1007\/s10620-011-2017-z","DOI":"10.1007\/s10620-011-2017-z"},{"key":"10.32074\/1591-951X-241_ref17","doi-asserted-by":"crossref","unstructured":"Zeman MV, Hirschfield GM. Autoantibodies and liver disease: uses and abuses. Can J Gastroenterol 2010;24:225-231. doi:10.1155\/2010\/431913","DOI":"10.1155\/2010\/431913"},{"key":"10.32074\/1591-951X-241_ref18","doi-asserted-by":"crossref","unstructured":"Wijeyesinghe U, Russell AS. Outcome of high titer antinuclear antibody positivity in individuals without connective tissue disease: a 10-year follow-up. Clin Rheumatol 2008;27:1399-402. https:\/\/doi.org\/10.1007\/s10067-008-0932-y","DOI":"10.1007\/s10067-008-0932-y"},{"key":"10.32074\/1591-951X-241_ref19","doi-asserted-by":"crossref","unstructured":"Kavanaugh A, Tomar R, Reveille J, et al. Guidelines for clinical use of the antinuclear antibody test and tests for specific autoantibodies to nuclear antigens. American College of Pathologists. Arch Pathol Lab Med 2000;124:71-81. https:\/\/doi.org\/10.1043\/0003-9985(2000)124<0071:GFCUOT>2.0.CO;2","DOI":"10.5858\/2000-124-0071-GFCUOT"},{"key":"10.32074\/1591-951X-241_ref20","doi-asserted-by":"crossref","unstructured":"Cassani F, Cataleta M, Valentini P, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997;26:561-6. https:\/\/doi.org\/10.1002\/hep.510260305","DOI":"10.1002\/hep.510260305"},{"key":"10.32074\/1591-951X-241_ref21","doi-asserted-by":"crossref","unstructured":"Vuppalanchi R, Gould RJ, Wilson LA, et al. Clinical significance of serum autoantibodies in patients with NAFLD: results from the nonalcoholic steatohepatitis clinical research network. Hepatol Int 2012;6:379-385. https:\/\/doi.org\/10.1007\/s12072-011-9277-8","DOI":"10.1007\/s12072-011-9277-8"},{"key":"10.32074\/1591-951X-241_ref22","doi-asserted-by":"crossref","unstructured":"Takahashi H, Zeniya M. Acute presentation of autoimmune hepatitis: Does it exist? A published work review. Hepatol Res 2011;41:498-504. https:\/\/doi.org\/10.1111\/j.1872-034X.2011.00808.x","DOI":"10.1111\/j.1872-034X.2011.00808.x"},{"key":"10.32074\/1591-951X-241_ref23","doi-asserted-by":"crossref","unstructured":"Miyake Y, Iwasaki Y, Terada R, et al. Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther 2006;23:1347-1353. https:\/\/doi.org\/10.1111\/j.1365-2036.2006.02894.x","DOI":"10.1111\/j.1365-2036.2006.02894.x"},{"key":"10.32074\/1591-951X-241_ref24","doi-asserted-by":"crossref","unstructured":"Abe M, Mashiba T, Zeniya M, et al. Present status of autoimmune hepatitis in Japan: a nationwide survey. J Gastroenterol 2011;46:1136-1141. https:\/\/doi.org\/10.1007\/s00535-011-0421-y","DOI":"10.1007\/s00535-011-0421-y"},{"key":"10.32074\/1591-951X-241_ref25","doi-asserted-by":"crossref","unstructured":"Lohse AW, Mieli-Vergani G. Autoimmune hepatitis. J Hepatol 2011;55:171-182. https:\/\/doi.org\/10.1016\/j.jhep.2010.12.012","DOI":"10.1016\/j.jhep.2010.12.012"},{"key":"10.32074\/1591-951X-241_ref26","doi-asserted-by":"crossref","unstructured":"Manns MP, Czaja AJ, Gorham JD, et al. Diagnosis and management of autoimmune hepatitis. Hepatology 2010;51:2193-2213. https:\/\/doi.org\/10.1002\/hep.23584","DOI":"10.1002\/hep.23584"},{"key":"10.32074\/1591-951X-241_ref27","doi-asserted-by":"crossref","unstructured":"Gleeson D, Heneghan MA. British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis. Gut 2011;60:1611-1629. https:\/\/doi.org\/10.1136\/gut.2010.235259","DOI":"10.1136\/gut.2010.235259"},{"key":"10.32074\/1591-951X-241_ref28","doi-asserted-by":"crossref","unstructured":"Czaja AJ. Autoimmune hepatitis in special patient populations. Best Pract Res Clin Gastroenterol 2011;25:689-700. https:\/\/doi.org\/10.1016\/j.bpg.2011.09.011","DOI":"10.1016\/j.bpg.2011.09.011"},{"key":"10.32074\/1591-951X-241_ref29","doi-asserted-by":"crossref","unstructured":"Tiniakos DG, Brain JG, Bury YA. Role of histopathology in autoimmune hepatitis. Dig Dis 2015;33 Suppl 2:53-64. https:\/\/doi.org\/10.1159\/000440747","DOI":"10.1159\/000440747"},{"key":"10.32074\/1591-951X-241_ref30","doi-asserted-by":"crossref","unstructured":"Guindi M. Histology of autoimmune hepatitis and its variants. Clin Liver Dis 2010;14: 577-590. https:\/\/doi.org\/10.1016\/j.cld.2010.07.003","DOI":"10.1016\/j.cld.2010.07.003"},{"key":"10.32074\/1591-951X-241_ref31","doi-asserted-by":"crossref","unstructured":"Gurung A, Assis DN, McCarty TR, et al. Histologic features of autoimmune hepatitis: a critical appraisal. Hum Pathol 2018;82:51-60. https:\/\/doi.org\/10.1016\/j.humpath.2018.07.014","DOI":"10.1016\/j.humpath.2018.07.014"},{"key":"10.32074\/1591-951X-241_ref32","unstructured":"Rubio CA, Truskaite K, Rajani R, et al. A method to assess the distribution and frequency of plasma cells and plasma cell precursors in autoimmune hepatitis. Anticancer Res 2013;33:665-669."},{"key":"10.32074\/1591-951X-241_ref33","doi-asserted-by":"crossref","unstructured":"Washington MK, Manns MP. Autoimmune hepatitis. In: Burt AD, Portmann B, Ferrel L, eds. MacSween\u2019s Pathology of the Liver. Edinburgh: Churchill Livingstone 2012, pp 467-490.","DOI":"10.1016\/B978-0-7020-3398-8.00009-X"},{"key":"10.32074\/1591-951X-241_ref34","doi-asserted-by":"crossref","unstructured":"Verdonk RC, Lozano MF, van den Berg AP, et al. Bile ductal injury and ductular reaction are frequent phenomena with different significance in autoimmune hepatitis. Liver Int 2016 Sep;36(9):1362-1369. https:\/\/doi.org\/10.1111\/liv.13083","DOI":"10.1111\/liv.13083"},{"key":"10.32074\/1591-951X-241_ref35","doi-asserted-by":"crossref","unstructured":"Okano N, Yamamoto K, Sakaguchi K, et al. Clinicopathological features of acute-onset autoimmune hepatitis. Hepatol Res 2003;25:263-270. https:\/\/doi.org\/10.1016\/s1386-6346(02)00274-7","DOI":"10.1016\/S1386-6346(02)00274-7"},{"key":"10.32074\/1591-951X-241_ref36","doi-asserted-by":"crossref","unstructured":"Hofer H, Oesterreicher C, Wrba F, et al. Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation. J Clin Pathol 2006;59:246-249. https:\/\/doi.org\/10.1136\/jcp.2005.029348","DOI":"10.1136\/jcp.2005.029348"},{"key":"10.32074\/1591-951X-241_ref37","doi-asserted-by":"crossref","unstructured":"de Boer YS, van Nieuwkerk CM, Witte BI, et al. Assessment of the histopathological key features in autoimmune hepatitis. Histopathology 2015;66:351-362. https:\/\/doi.org\/10.1111\/his.12558","DOI":"10.1111\/his.12558"},{"key":"10.32074\/1591-951X-241_ref38","doi-asserted-by":"crossref","unstructured":"Miao Q, Bian Z, Tang R, et al. Emperipolesis mediated by CD8 T cells is a characteristic histopathologic feature of autoimmune hepatitis. Clin Rev Allergy Immunol 2015;48(2-3):226-235. https:\/\/doi.org\/10.1007\/s12016-014-8432-0","DOI":"10.1007\/s12016-014-8432-0"},{"key":"10.32074\/1591-951X-241_ref39","doi-asserted-by":"crossref","unstructured":"Czaja AJ, Carpenter HA. Autoimmune hepatitis with incidental histologic features of bile duct injury. Hepatology 2001;34(4 Pt 1):659-665. https:\/\/doi.org\/10.1053\/jhep.2001.27562","DOI":"10.1053\/jhep.2001.27562"},{"key":"10.32074\/1591-951X-241_ref40","doi-asserted-by":"crossref","unstructured":"Zen Y, Harada K, Sasaki M, et al. Are bile duct lesions of primary biliary cirrhosis distinguishable from those of autoimmune hepatitis and chronic viral hepatitis? Interobserver histological agreement on trimmed bile ducts. J Gastroenterol 2005;40:164-170. https:\/\/doi.org\/10.1007\/s00535-004-1514-7","DOI":"10.1007\/s00535-004-1514-7"},{"key":"10.32074\/1591-951X-241_ref41","doi-asserted-by":"crossref","unstructured":"Balitzer D, Shafizadeh N, Peters MG, et al. Autoimmune hepatitis: review of histologic features included in the simplified criteria proposed by the international autoimmune hepatitis group and proposal for new histologic criteria. Mod Pathol 2017;30:773-783. https:\/\/doi.org\/10.1038\/modpathol.2016.267","DOI":"10.1038\/modpathol.2016.267"},{"key":"10.32074\/1591-951X-241_ref42","doi-asserted-by":"crossref","unstructured":"Bihari C, Rastogi A, Sarin SK. Postinfantile giant cell hepatitis: an etiological and prognostic perspective. Hepat Res Treat 2013;2013:601290. https:\/\/doi.org\/10.1155\/2013\/601290","DOI":"10.1155\/2013\/601290"},{"key":"10.32074\/1591-951X-241_ref43","doi-asserted-by":"crossref","unstructured":"Tucker SM, Jonas MM, Perez-Atayde AR. Hyaline droplets in Kupffer cells: a novel diagnostic clue for autoimmune hepatitis. Am J Surg Pathol 2015;39:772-778. https:\/\/doi.org\/10.1097\/PAS.0000000000000395","DOI":"10.1097\/PAS.0000000000000395"},{"key":"10.32074\/1591-951X-241_ref44","doi-asserted-by":"crossref","unstructured":"Scheuer PJ: Classification of chronic viral hepatitis: a need for reassessment. J Hepatol 1991;13: 372-374. https:\/\/doi.org\/10.1016\/0168-8278(91)90084-o","DOI":"10.1016\/0168-8278(91)90084-O"},{"key":"10.32074\/1591-951X-241_ref45","doi-asserted-by":"crossref","unstructured":"Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995;22:696-699. https:\/\/doi.org\/10.1016\/0168-8278(95)80226-6","DOI":"10.1016\/0168-8278(95)80226-6"},{"key":"10.32074\/1591-951X-241_ref46","doi-asserted-by":"crossref","unstructured":"The French METAVIR cooperative study group. Intraobserver and interobserver variations in liver biopsy interpretation in patients with chronic hepatitis C. Hepatology 1994;20:15-20.","DOI":"10.1002\/hep.1840200104"},{"key":"10.32074\/1591-951X-241_ref47","doi-asserted-by":"crossref","unstructured":"Fujiwara S, Yokokawa Y, Morino K, et al. Chronic hepatitis E: a review of the literature. J Viral Hepat 2014;21:78-89. https:\/\/doi.org\/10.1111\/jvh.12156","DOI":"10.1111\/jvh.12156"},{"key":"10.32074\/1591-951X-241_ref48","doi-asserted-by":"crossref","unstructured":"Lenggenhager D, Pawel S, Honcharova-Biletska H, et al. The histologic presentation of hepatitis E reflects patients\u2019 immune status and pre-existing liver condition. Mod Pathol 2021;34:233-248. https:\/\/doi.org\/10.1038\/s41379-020-0593-1","DOI":"10.1038\/s41379-020-0593-1"},{"key":"10.32074\/1591-951X-241_ref49","doi-asserted-by":"crossref","unstructured":"Lenggenhager D, Weber A. Clinicopathologic features and pathologic diagnosis of hepatitis E. Hum Pathol 2020;96:34-38. https:\/\/doi.org\/10.1016\/j.humpath.2019.10.003","DOI":"10.1016\/j.humpath.2019.10.003"},{"key":"10.32074\/1591-951X-241_ref50","doi-asserted-by":"crossref","unstructured":"Kleiner DE. Recent Advances in the histopathology of drug-induced liver injury. Surg Pathol Clin 2018;11:297-311. https:\/\/doi.org\/10.1016\/j.path.2018.02.009","DOI":"10.1016\/j.path.2018.02.009"},{"key":"10.32074\/1591-951X-241_ref51","doi-asserted-by":"crossref","unstructured":"Garcia-Buey L, Garcia-Monzon C, Rodriguez S, et al. Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 1995;108:1770-1777. https:\/\/doi.org\/10.1016\/0016-5085(95)90139-6","DOI":"10.1016\/0016-5085(95)90139-6"},{"key":"10.32074\/1591-951X-241_ref52","doi-asserted-by":"crossref","unstructured":"Takahashi A, Kanno Y, Takahashi Y, et al. Development of autoimmune hepatitis type 1 after pulsed methylprednisolone therapy for multiple sclerosis: a case report. World J Gastroenterol 2008;14:5474-5477. https:\/\/doi.org\/10.3748\/wjg.14.5474","DOI":"10.3748\/wjg.14.5474"},{"key":"10.32074\/1591-951X-241_ref53","doi-asserted-by":"crossref","unstructured":"Kleiner DE. Histopathological challenges in suspected drug-induced liver injury. Liver Int 2018 38:198-209. https:\/\/doi.org\/10.1111\/liv.13584","DOI":"10.1111\/liv.13584"},{"key":"10.32074\/1591-951X-241_ref54","doi-asserted-by":"crossref","unstructured":"Suzuki A, Brunt EM, Kleiner DE, et al. The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug-induced liver injury. Hepatology 2011;54:931-939. https:\/\/doi.org\/10.1002\/hep.24481","DOI":"10.1002\/hep.24481"},{"key":"10.32074\/1591-951X-241_ref55","doi-asserted-by":"crossref","unstructured":"Schilsky ML. Wilson disease: genetic basis of copper toxicity and natural history. Semin Liver Dis 1996;16:83-95. https:\/\/doi.org\/10.1055\/s-2007-1007221","DOI":"10.1055\/s-2007-1007221"}],"container-title":["Pathologica"],"original-title":[],"link":[{"URL":"https:\/\/www.pathologica.it\/article\/view\/241","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T13:25:35Z","timestamp":1730813135000},"score":1,"resource":{"primary":{"URL":"https:\/\/old.pathologica.it\/article\/view\/241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":55,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.32074\/1591-951x-241","relation":{},"ISSN":["1591-951X"],"issn-type":[{"value":"1591-951X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6]]},"article-number":"4"}}